Lv1
42 积分 2024-11-05 加入
The evaluation and management of leukopenia
1个月前
已完结
Re-examining the utility and validity of benign ethnic neutropenia: A narrative literature review
1个月前
已关闭
Atopic dermatitis relapse after treatment discontinuation and predictive factors for relapse: JAK1 inhibitors versus dupilumab
2个月前
已完结
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study
5个月前
已完结
Anterior Segment Manifestations and Complications of Systemic Drug Therapy
5个月前
已完结
Comprehensive Ophthalmological Evaluation in Atopic Dermatitis
5个月前
已关闭
Beyond Infusion: Real-World Insights Into Infusion-Related Reactions in Monoclonal Antibody Therapy
5个月前
已关闭
The paradigm shift in drug development for atopic dermatitis: Addressing the variables of the equation leading to disease modification
5个月前
已完结
382 Lebrikizumab provides clinically meaningful improvements in atopic dermatitis in patients previously treated with dupilumab
5个月前
已关闭
皖公网安备34019202002308
